BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 13835652)

  • 21. Studies on the biological interrelationships of folic acid, citrovorum factor, and the antimetabolite, aminopterin.
    GOLDIN A; GREENSPAN EM; VENDITTI JM; SCHOENBACH EB
    J Natl Cancer Inst; 1952 Apr; 12(5):987-1002. PubMed ID: 14928052
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of methotrexate on basal-cell carcinomas.
    VAN SCOTT EJ; SHAW RK; CROUNSE RG; CONDIT PT
    Arch Dermatol; 1960 Nov; 82():762-71. PubMed ID: 13780054
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on the mechanism of action of chemotherapeutic agents in cancer. V. Influence of the citrovorum factor and folic acid on the toxic manifestations of aminopterin in mice.
    GREENSPAN EM; GOLDIN A; SCHOENBACH EB
    Cancer; 1951 May; 4(3):619-25. PubMed ID: 14839616
    [No Abstract]   [Full Text] [Related]  

  • 24. Trans-stimulation effects of folic acid derivatives on methotrexate transport by rat renal organic anion transporter, OAT-K1.
    Takeuchi A; Masuda S; Saito H; Hashimoto Y; Inui K
    J Pharmacol Exp Ther; 2000 Jun; 293(3):1034-9. PubMed ID: 10869408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of methotrexate orally in treatment of squamous cancers of the head and neck.
    HUSEBY RA; DOWNING V
    Cancer Chemother Rep; 1962 Feb; 16():511-4. PubMed ID: 14036458
    [No Abstract]   [Full Text] [Related]  

  • 26. Development of resistance to 4-amino n10-methyl pteroylglutamic acid (Amethopterin) by Leuconostoc citrovorum.
    HUTCHISON DJ; BURCHENAL JH
    Proc Soc Exp Biol Med; 1952 Jul; 80(3):516-8. PubMed ID: 14949104
    [No Abstract]   [Full Text] [Related]  

  • 27. Report of a case of choriocarcinoma treated with methotrexate.
    HAMILTON JK
    J Obstet Gynaecol Br Emp; 1962 Feb; 69():58-62. PubMed ID: 13904108
    [No Abstract]   [Full Text] [Related]  

  • 28. Cancer chemotherapy by arterial infusion.
    BENSON JW; KIEHN CL; HOLDEN WD
    Arch Surg; 1963 Jul; 87():125-44. PubMed ID: 13967518
    [No Abstract]   [Full Text] [Related]  

  • 29. Combination chemotherapy of advanced ovarian carcinoma with the antimetabolite, methotrexate, and the alkylating agent, thioTEPA.
    GREENSPAN EM; FIEBER M
    J Mt Sinai Hosp N Y; 1962; 29():48-62. PubMed ID: 13901566
    [No Abstract]   [Full Text] [Related]  

  • 30. Intrathecal amethopterin in 2 cases of spinal cord involvement due to metastatic nasopharyngeal carcinoma and Hodgkin's disease.
    ABD-EL GHAFFAR Y
    Cancer; 1960; 13():677-9. PubMed ID: 13791395
    [No Abstract]   [Full Text] [Related]  

  • 31. Bronchogenic carcinoma. A comparative study of the palliative effects of radiation therapy, radiation therapy plus nitrogen mustard, and radiation therapy plus amethopterin and actinomycin D in combination.
    ALEXANDER LL; CAUSING J; SCHWINGER HN; LI MC
    Am J Roentgenol Radium Ther Nucl Med; 1962 Feb; 87():375-84. PubMed ID: 13860344
    [No Abstract]   [Full Text] [Related]  

  • 32. Metabolism of citrovorum factor and folic acid in gout; urinary excretion studies.
    DILG S; FALLON WW
    J Lab Clin Med; 1956 Sep; 48(3):399-412. PubMed ID: 13367577
    [No Abstract]   [Full Text] [Related]  

  • 33. Remissions produced with the use of Methotrexate in patients with mycosis fungoides.
    WRIGHT JC; GUMPORT SL; GOLOMB FM
    Cancer Chemother Rep; 1960 Nov; 9():11-20. PubMed ID: 13786791
    [No Abstract]   [Full Text] [Related]  

  • 34. Methotrexate in treatment of metastasizing chorioncarcinoma: a case report.
    BUCKLE AE
    Br Med J; 1959 Dec; 2(5161):1210-3. PubMed ID: 13805579
    [No Abstract]   [Full Text] [Related]  

  • 35. Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein.
    Westerhof GR; Rijnboutt S; Schornagel JH; Pinedo HM; Peters GJ; Jansen G
    Cancer Res; 1995 Sep; 55(17):3795-802. PubMed ID: 7641196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of folic acid and citrovorum factor in metabolic processes and their relation to cancer.
    BROQUIST HP
    Tex Rep Biol Med; 1952; 10(4):953-60. PubMed ID: 13028998
    [No Abstract]   [Full Text] [Related]  

  • 37. [Folic acid and citrovorum factor in the liver of rats with thyrotoxicosis].
    MARCHETTI M; VIVIANI R
    Boll Soc Ital Biol Sper; 1959 Dec; 35():2171-3. PubMed ID: 14420900
    [No Abstract]   [Full Text] [Related]  

  • 38. The inhibition of dehydrogenases by folic acid and several of its analogs.
    VOGEL WH; SNYDER R; SCHULMAN MP
    Biochem Biophys Res Commun; 1963 Jan; 10():97-101. PubMed ID: 13997658
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of methotrexate in secondary chorionepithelioma; report of a case.
    MANLY GA
    J Obstet Gynaecol Br Commonw; 1961 Apr; 68():277-9. PubMed ID: 13766195
    [No Abstract]   [Full Text] [Related]  

  • 40. Adjuvant therapy of choriocarcinoma with methotrexate.
    PERLSON SG; WHITSITT RE
    Obstet Gynecol; 1960 Feb; 15():175-81. PubMed ID: 14431905
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.